Farther Finance Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.6M Buy
43,809
+1,615
+4% +$1.65M 0.41% 42
2026
Q1
$40.3M Buy
42,194
+11,049
+35% +$11.2M 0.38% 49
2025
Q4
$33.5M Buy
31,145
+7,338
+31% +$7.02M 0.36% 54
2025
Q3
$18.2M Buy
23,807
+312
+1% +$232K 0.27% 67
2025
Q2
$18.3M Buy
23,495
+5,670
+32% +$4.41M 0.37% 47
2025
Q1
$14.4M Buy
17,825
+3,700
+26% +$3.08M 0.37% 51
2024
Q4
$10.9M Buy
14,125
+152
+1% +$126K 0.39% 52
2024
Q3
$12.4M Buy
13,973
+1,520
+12% +$1.37M 0.46% 36
2024
Q2
$11.4M Buy
12,453
+4,157
+50% +$3.33M 0.55% 32
2024
Q1
$6.31M Buy
8,296
+652
+9% +$464K 0.38% 50
2023
Q4
$4.46M Buy
7,644
+2,350
+44% +$1.37M 0.32% 63
2023
Q3
$2.84M Buy
5,294
+1,743
+49% +$898K 0.45% 42
2023
Q2
$1.67M Buy
3,551
+2,819
+385% +$1.18M 0.36% 56
2023
Q1
$251K Sell
732
-50
-6% -$16.9K 0.07% 235
2022
Q4
$286K Buy
+782
New +$277K 0.11% 181

Other funds holding LLY

Farther Finance Advisors's LLY Position: Q2 2026 in Review

Farther Finance Advisors increased its Eli Lilly (LLY) stake by 3.8% in Q2 2026, buying an estimated $1.65M and bringing the position to 43,809 shares worth $52.6M. The position accounts for 0.41% of the portfolio, ranked #42.

Farther Finance Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Farther Finance Advisors held 43,809 shares of Eli Lilly worth $52.6M as of Q2 2026.
  • Farther Finance Advisors bought 1,615 Eli Lilly shares in Q2 2026, an estimated $1.65M.
  • Eli Lilly made up 0.41% of Farther Finance Advisors's portfolio in Q2 2026, its #42 holding.
  • Farther Finance Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.